Incidence and prognostic value of HER2-low expression metastatic breast cancer in Asian population: A 10-year retrospective study

被引：0
|
作者：
Dajsakdipon, T. [1 ]
Pipatsakulroj, W. [2 ]
Dejthevaporn, T. [3 ]
机构：
[1] Ramathibodi Hosp, Dept Med, Bangkok, Thailand
[2] Mahidol Univ, Fac Med, Ramathibodi Hosp, Dept Pathol, Bangkok, Thailand
[3] Mahidol Univ, Fac Med, Ramathibodi Hosp, Internal Med Dept, Bangkok, Thailand
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.610
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
434P
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [1] Heterogeneity and prognostic characteristics of HER2-low breast cancer: A retrospective analysis of patients with HER2-negative metastatic breast cancer
    Lv, Huimin
    Yan, Min
    Zhang, Mengwei
    Niu, Limin
    Zeng, Huiai
    Sun, Huihui
    Zhao, Shengnan
    Wang, Jing
    CANCER RESEARCH, 2024, 84 (09)
  • [2] Understanding metastatic breast cancer: a 10-year retrospective study
    Chelu, A.
    Barna, R. A.
    Nataras, B.
    Iacob, M.
    Anderco, D.
    Suciu, C.
    Lazureanu, C.
    Muresan, A.
    Cornianu, M.
    Taban, S.
    Dema, A.
    VIRCHOWS ARCHIV, 2024, 485 : S52 - S52
  • [3] Outcome of patients with HER2-positive brain metastatic breast cancer: A 10-year retrospective study
    Bigot, C.
    Bischoff, H.
    Chambrelant, I.
    Demarchi, M. F.
    Petit, T.
    Kurtz, J. E.
    Pierard, L.
    Pflumio, C.
    Alt, M.
    Fischbach, C.
    Weindling, M. Kalish
    Lefevre, C.
    Noel, G.
    Cox, D.
    Pivot, X.
    Trensz, P.
    Bender, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S489 - S489
  • [4] Prognostic value of HER2-low expression according to hormone receptor status in breast cancer patients
    Huszno, J.
    Kolosza, Z.
    Stobiecka, E.
    Ponikiewska, D.
    Szczesniak, B.
    Simek, J.
    Chmielik, E.
    BREAST, 2025, 80
  • [5] Clinicopathological characteristics of HER2-low breast cancer: a retrospective study
    Man Yang
    Jiale Sun
    Liqiong Liu
    Xiangyi Kong
    Dongcai Lin
    Hong Zhou
    Jidong Gao
    Scientific Reports, 13 (1)
  • [6] Clinicopathological characteristics of HER2-low breast cancer: a retrospective study
    Yang, Man
    Sun, Jiale
    Liu, Liqiong
    Kong, Xiangyi
    Lin, Dongcai
    Zhou, Hong
    Gao, Jidong
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [7] Prognostic and biologic significance of HER2-low expression in early breast cancer
    Tarantino, P.
    Jin, Q.
    Tayob, N.
    Jeselsohn, R.
    Schnitt, S. J.
    Vincuilla, J.
    Parker, T.
    Tyekucheva, S.
    Lin, N. U.
    Hughes, M.
    Weiss, A. C.
    King, T. A.
    Mittendorf, E. A.
    Curigliano, G.
    Tolaney, S. M.
    ANNALS OF ONCOLOGY, 2022, 33 : S124 - S124
  • [8] Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers
    Jacot, William
    Maran-Gonzalez, Aurelie
    Massol, Oceane
    Sorbs, Charlotte
    Mollevi, Caroline
    Guiu, Severine
    Boissiere-Michot, Florence
    Ramos, Jeanne
    CANCERS, 2021, 13 (23)
  • [9] Prognostic value of HER2-low status in breast cancer: A systematic review and metaanalysis
    Molinelli, Chiara
    Jacobs, Flavia
    Agostinetto, Elisa
    Marta, Guilherme Nader
    Ceppi, Marcello
    Bruzzone, Marco
    Blondeaux, Eva
    Schettini, Francesco
    Prat, Aleix
    Viale, Giuseppe
    Del Mastro, Lucia
    Lambertini, Matteo
    de Azambuja, Evandro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study
    Narita, Yukiya
    Mizuno, Taro
    Ishizuka, Yasunobu
    Sakakida, Tomoki
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Kadowaki, Shigenori
    Honda, Kazunori
    Ando, Masashi
    Tajika, Masahiro
    Takahari, Daisuke
    Muro, Kei
    ONCOLOGIST, 2024,
12345